Fielkow Jeffrey A

Director Fielkow buys 2,000 TRS shares at $31.46; 4 prior TRS purchases all returned +4.4% to +47.2% at 90-day mark.

Director Jeffrey A Fielkow purchased 2,000 shares at $31.46, expanding his TRS holdings by 12.8% to 17,653 shares post-transaction. This is his fifth open-market purchase at this ticker; his prior four TRS buys, spanning from May 2023 to May 2025, each realized positive 90-day returns ranging from +4.4% to +47.2%, with a 100% success rate at the 90-day mark. His cross-ticker track record across all holdings also shows 4 prior buys with an average 90-day return of +22.8% and a 100.00% win rate. The current price of $31.72 sits near the transaction price, -20.7% from the 52-week high and down -14.2% over the past 90 days. The consistent pattern of positive 90-day outcomes across both his TRS-specific history and broader buy history provides a data-grounded reference point for assessing the signal, though the company's elevated P/E of 29.37 and modest recent fundamentals (revenue growth +3.5%, net income $9.3M on $269.3M revenue) warrant investor monitoring of near-term execution.

Director Fielkow buys 500 TRS shares at $24.98; joins 2-insider cluster buy pattern within 14 days.

Fielkow Jeffrey A, a director at TriMas, purchased 500 shares at $24.98 on 2025-05-19, adding to his post-transaction holdings of 15,653 shares. This purchase occurs within a 14-day window in which two other insiders also bought, forming a cluster buy pattern that suggests broader confidence in the stock at current levels. Across his same-ticker history at TRS, Fielkow has executed three prior open-market purchases, with measurable outcomes showing +12.3% at 30 days (2025-02-28 buy) and +11.2% / +11.6% (30-day / 90-day returns) on his 2024-03-04 purchase, indicating a pattern of well-timed entries at this ticker over a 2-year span. The current price of $25.65 is approximately 2.7% above the transaction price and +26.7% over the past 30 days, placing the trade near the upper half of the 52-week range ($19.90–$28.32); the stock remains -9.4% from its 52-week high, suggesting room for further appreciation if the company's quarterly revenue of $241,670,000 and net income of $12,420,000 sustain momentum.

Director Fielkow buys 2,500 shares of TRS at $20.78 amid cluster activity; prior TRS buys both posted +11.2% and +4.4% 90d returns.

Jeffrey A Fielkow, a Director, purchased 2,500 shares at $20.78 on 2025-02-28, growing his TRS holdings by 29.4% to 11,013 shares. This buy occurs at a price that is -26.0% from the 52-week high and follows two prior open-market purchases at this ticker: one on 2024-03-04 (which returned +11.2% in 30 days and +11.6% in 90 days) and another on 2023-05-04 (which returned +5.7% and +4.4% respectively). Both prior same-ticker purchases proved well-timed by the 90-day mark, indicating a pattern of entry timing. The current purchase is concurrent with a cluster of 3 other insider buys within the past 14 days, which may signal coordinated shareholder-friendly positioning despite stock prices that are down -13.7% in 30 days and -21.1% in 90 days. However, TRS's elevated P/E of 80.62 and modest net income of $2.5M against $229.4M revenue warrant attention to whether near-term fundamental recovery supports these purchases.